Stockscreener 앱 받기
44.16
3.33%
-1.52
시간 외 거래:
44.16
전일 마감가:
$45.68
열려 있는:
$45.32
하루 거래량:
3.54M
Relative Volume:
2.90
시가총액:
$9.90B
수익:
$2.04B
순이익/손실:
$373.39M
주가수익비율:
26.04
EPS:
1.6961
순현금흐름:
$495.96M
1주 성능:
-7.90%
1개월 성능:
-5.64%
6개월 성능:
+2.39%
1년 성능:
-1.64%
1일 변동 폭
$43.26
$47.39
1주일 범위
$43.26
$47.82
52주 변동 폭
$37.74
$51.88
Qiagen Nv Stock (QGEN) Company Profile
QGEN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
44.16 | 9.90B | 2.04B | 373.39M | 495.96M | 1.6961 |
|
TMO
Thermo Fisher Scientific Inc
|
565.24 | 212.23B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
213.83 | 151.20B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
722.12 | 57.84B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
146.08 | 41.02B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
210.96 | 36.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-24 | 개시 | Barclays | Overweight |
| 2025-04-04 | 다운그레이드 | Redburn Atlantic | Buy → Neutral |
| 2025-02-19 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-01-06 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-12-10 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-10-17 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2024-06-27 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-12-19 | 개시 | Wells Fargo | Equal Weight |
| 2023-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2023-12-07 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-09-12 | 개시 | Robert W. Baird | Outperform |
| 2023-05-23 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-18 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-01-18 | 업그레이드 | DZ Bank | Hold → Buy |
| 2021-10-15 | 재개 | Cowen | Market Perform |
| 2021-10-14 | 개시 | Redburn | Buy |
| 2021-07-14 | 다운그레이드 | Kepler | Buy → Hold |
| 2021-06-03 | 개시 | Goldman | Neutral |
| 2020-10-06 | 재개 | BofA Securities | Buy |
| 2020-09-28 | 업그레이드 | Kepler | Hold → Buy |
| 2020-08-24 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-08-20 | 재개 | JP Morgan | Overweight |
| 2020-08-17 | 업그레이드 | Berenberg | Hold → Buy |
| 2020-08-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2020-08-14 | 업그레이드 | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-04 | 다운그레이드 | Berenberg | Buy → Hold |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Neutral |
| 2019-12-26 | 재개 | BofA/Merrill | Underperform |
| 2019-11-15 | 개시 | Stifel | Hold |
| 2019-11-14 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2019-11-14 | 업그레이드 | JP Morgan | Underweight → Overweight |
| 2019-11-14 | 업그레이드 | Kepler | Reduce → Hold |
| 2019-10-17 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2019-10-09 | 다운그레이드 | Kepler | Hold → Reduce |
| 2019-10-08 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2019-10-08 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2019-10-08 | 다운그레이드 | JP Morgan | Neutral → Underweight |
모두보기
Qiagen Nv 주식(QGEN)의 최신 뉴스
Qiagen: Q3 Earnings Snapshot - News-Times
Qiagen Lifts Earnings Outlook But Shares Slip On Results - Finimize
QIAGEN reports 6% sales growth in Q3, raises full-year EPS outlook - Investing.com Australia
Qiagen N.V. Reaffirms Earnings Guidance for the Fiscal Year 2025 - MarketScreener
(QGEN) QIAGEN Expects Q4 Adjusted EPS $0.60, vs. FactSet Est of $0.61 - MarketScreener
Qiagen to Acquire Parse Biosciences for Up to $280 Million to Expand Single-Cell Portfolio - MarketScreener
(QGEN) QIAGEN Revises Full Year 2025 Adjusted EPS Outlook To About $2.38, vs. FactSet Est of $2.34 - MarketScreener
Qiagen (QGEN) Raises Earnings Outlook for 2025 - GuruFocus
Qiagen (QGEN) to Acquire Parse Biosciences, Boosting Single-Cell Research Capabilities - GuruFocus
Qiagen to return $500M to shareholders through synthetic share repurchase - TipRanks
Qiagen reports Q3 adjusted EPS 61c, consensus 59c - TipRanks
Qiagen to acquire Parse Biosciences for up to $280M - TipRanks
Qiagen NV raises FY adjusted EPS target to about $2.38 CER - MarketScreener
QIAGEN N.V.: QIAGEN announces CEO transition plan - MarketScreener
QIAGEN Exceeds Q3 2025 Outlook, Raises FY 2025 Adj. EPS Target, Announces Parse Acquisition and $500 Million Share Repurchase - Business Wire
QIAGEN N.V.: QIAGEN to return approximately $500 million to shareholders through a synthetic share repurchase - MarketScreener
QIAGEN to acquire Parse Biosciences, expanding its Sample technologies portfolio into highly scalable single-cell solutions - Business Wire
Does The Market Have A Low Tolerance For Qiagen N.V.'s (NYSE:QGEN) Mixed Fundamentals? - 富途牛牛
Qiagen NV (QGEN) Q3 2025 Earnings Report Preview: What To Expect - GuruFocus
Will Qiagen N.V. (QIA) stock beat Nasdaq index returns2025 Valuation Update & Reliable Momentum Entry Alerts - newser.com
Is Qiagen N.V. (QIA) stock ideal for retirement investorsTreasury Yields & Community Consensus Trade Signals - newser.com
Is Qiagen N.V. stock attractive for passive investorsMarket Sentiment Review & Risk Adjusted Buy/Sell Alerts - newser.com
What data driven models say about Qiagen N.V.’s futureJuly 2025 Fed Impact & AI Based Buy and Sell Signals - newser.com
Is Qiagen N.V. stock a safe haven assetNew Guidance & Low Risk Entry Point Tips - newser.com
How Qiagen N.V. Common Shares stock performs in easing cyclesWeekly Earnings Recap & Daily Oversold Bounce Ideas - newser.com
Is Qiagen N.V. (QIA) stock overpriced at current multiples2025 Geopolitical Influence & Detailed Earnings Play Alerts - newser.com
Will Qiagen N.V. Common Shares stock sustain dividend payoutsPortfolio Return Report & Weekly Market Pulse Updates - newser.com
Why Qiagen N.V. (QIA) stock is listed among top recommendationsRate Cut & Expert Curated Trade Setup Alerts - newser.com
Full technical analysis of Qiagen N.V. stockWeekly Profit Summary & Long-Term Capital Growth Strategies - newser.com
Can Qiagen N.V. stock hit record highs again2025 Market Overview & Weekly High Return Opportunities - newser.com
What downside risks could hit Qiagen N.V. Common Shares stockQuarterly Earnings Summary & Weekly Momentum Stock Picks - newser.com
Will Qiagen N.V. see short term momentumJuly 2025 Review & Weekly Breakout Watchlists - newser.com
What momentum shifts mean for Qiagen N.V.Quarterly Portfolio Summary & Community Verified Watchlist Alerts - newser.com
Qiagen NV (QGEN) Q3 2025: Everything You Need to Know Ahead of E - GuruFocus
Qiagen NV (QGEN) Q3 2025: Everything You Need to Know Ahead of Earnings - Yahoo Finance
Is Qiagen N.V. stock supported by strong fundamentals2025 Top Gainers & Smart Swing Trading Techniques - newser.com
Using portfolio simulators with Qiagen N.V. includedJuly 2025 Selloffs & Smart Swing Trading Techniques - newser.com
Can Qiagen N.V. stock sustain free cash flow growth2025 Momentum Check & Expert Curated Trade Ideas - newser.com
How Qiagen N.V. Common Shares stock trades after rate cutsStock Surge & Scalable Portfolio Growth Ideas - newser.com
What earnings revisions data tells us about Qiagen N.V.July 2025 Big Picture & Safe Entry Momentum Tips - newser.com
Is Qiagen N.V. stock cheap compared to fundamentals2025 Trading Volume Trends & Fast Gain Stock Trading Tips - newser.com
Momentum divergence signals in Qiagen N.V. chartMarket Sentiment Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Qiagen (NYSE:QGEN) Valuation in Focus as Forensic Automation and Lab Milestones Drive Future Growth Prospects - simplywall.st
QIAGEN launches new automated sexual assault sample processing kit - SelectScience
How to integrate Qiagen N.V. into portfolio analysis toolsVolume Spike & Weekly Watchlist of Top Performers - newser.com
What to expect from Qiagen N.V. in the next 30 daysJuly 2025 Catalysts & Weekly High Momentum Picks - newser.com
Why retail investors favor Qiagen N.V. stockGap Down & Entry and Exit Point Strategies - newser.com
Regression analysis insights on Qiagen N.V. performanceLong Setup & Risk Controlled Daily Trade Plans - newser.com
Volume spikes in Qiagen N.V. stock – what they meanPortfolio Gains Report & Real-Time Volume Spike Alerts - newser.com
Qiagen Nv (QGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.45%
6.29%
자본화:
|
볼륨(24시간):